-transparent.png){kind=logo}
A single 5-gm dose of mezlocillin or a placebo was administered intravenously 30 minutes before surgery to patients undergoing emergency cesarean section. The assignment of drug or placebo was randomized. Postoperative morbidity occurred in 62.5% of patients receiving placebo and in 18.4% of those receiving mezlocillin (P less than 0.001). The incidences of febrile morbidity, endometritis, and urinary tract infection were significantly lower in the group given mezlocillin. Other benefits of antibiotic prophylaxis included a shorter hospital stay and no serious infections in the group given mezlocillin.
Related Publications
R Jaffe, and
M Altaras, and
I Cohen, and
N Ben-Aderet
April 1983,
Obstetrics and gynecology,
R Jaffe, and
M Altaras, and
I Cohen, and
N Ben-Aderet
May 1988,
American journal of obstetrics and gynecology,
R Jaffe, and
M Altaras, and
I Cohen, and
N Ben-Aderet
July 1998,
Primary care update for Ob/Gyns,
R Jaffe, and
M Altaras, and
I Cohen, and
N Ben-Aderet
May 1986,
American journal of obstetrics and gynecology,
R Jaffe, and
M Altaras, and
I Cohen, and
N Ben-Aderet
January 1990,
Acta obstetricia et gynecologica Scandinavica,
R Jaffe, and
M Altaras, and
I Cohen, and
N Ben-Aderet
February 1985,
Obstetrics and gynecology,
R Jaffe, and
M Altaras, and
I Cohen, and
N Ben-Aderet
July 1998,
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
R Jaffe, and
M Altaras, and
I Cohen, and
N Ben-Aderet
July 1989,
Journal of chemotherapy (Florence, Italy),
R Jaffe, and
M Altaras, and
I Cohen, and
N Ben-Aderet
October 1986,
Southern medical journal,
R Jaffe, and
M Altaras, and
I Cohen, and
N Ben-Aderet
January 1983,
European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
